Diferencia entre revisiones de «Hyperphosphatemia»

Sin resumen de edición
 
(No se muestran 4 ediciones intermedias de 2 usuarios)
Línea 1: Línea 1:
==Background==
==Background==
*>4.5mg/dL<ref>Hawley C. Serum phosphate. Nephrology. Apr 2006. 11(S1):S201-5.</ref>
===Major Causes===
===Major Causes===
*Increased phosphate intake (Vitamin D, laxative abuse
*Increased phosphate intake (Vitamin D, laxative abuse)
*Decreased excretion ([[Renal failure]]
*Increased renal reabsorption ([[Hypoparathyroidism]])
*Decreased excretion ([[Renal failure]])
*Transcellular shifts ([[Tumor lysis syndrome]], [[Rhabdomyolysis]])
*Transcellular shifts ([[Tumor lysis syndrome]], [[Rhabdomyolysis]])


==Clinical Features==
==Clinical Features==
*Fatigue
*[[Fatigue]]
*[[Shortness of breath]]
*[[Shortness of breath]]
*Anorexia
*Anorexia
*[[Nausea]]
*[[Nausea]]
*[[Vomiting]]
*[[Vomiting]]
*Insomnia
*[[Insomnia]]


==Differential Diagnosis==
==Differential Diagnosis==
Línea 18: Línea 18:
*Vitamin D intoxication
*Vitamin D intoxication
*[[Tumor lysis syndrome]]
*[[Tumor lysis syndrome]]
*Laxative (Phospho-soda) abuse
*[[bulimia nervosa|Laxative (Phospho-soda) abuse]]
*[[Rhabdomyolysis]]
*[[Rhabdomyolysis]]
*Hypoparathyroidism
*[[Hypoparathyroidism]]
*Pseudohypoparathyroidism
*Pseudo[[hypoparathyroidism]]
*[[Multiple myeloma]]
*[[Multiple myeloma]]


==Evaluation==
==Evaluation==
*>4.5mg/dL<ref>Hawley C. Serum phosphate. Nephrology. Apr 2006. 11(S1):S201-5.</ref>
===Labs===
===Labs===
Symptoms usually related to associated renal failure, [[hypocalcemia]] or [[hypomagnesemia]]
Symptoms usually related to associated renal failure, [[hypocalcemia]] or [[hypomagnesemia]]
Línea 32: Línea 33:
{{Hyperphosphatemia treatment}}
{{Hyperphosphatemia treatment}}


==References==
==Disposition==
<references/>


==See Also==
==See Also==
*[[Electrolyte Abnormalities (Main)]]
*[[Electrolyte Abnormalities (Main)]]
==References==
<references/>


[[Category:FEN]]
[[Category:FEN]]

Revisión actual - 22:47 9 jun 2023

Background

Major Causes

Clinical Features

Differential Diagnosis

Evaluation

Labs

Symptoms usually related to associated renal failure, hypocalcemia or hypomagnesemia

  • Metabolic Panel (with calcium, Magnesium, and Phosphorus)

Management

Hyperphosphatemia treatment

  • Treat the underlying cause
  • Restrict calcium phosphate intake
  • IV Normal Saline (if normal renal fx)
  • Acetazolamide (500mg IV q6hr) - if normal renal function
  • Phosphate Binder - Aluminum hydroxide (50-150mg/kg PO q4-6h) - limited effect
  • Dialysis if refractory

Disposition

See Also

References

  1. Hawley C. Serum phosphate. Nephrology. Apr 2006. 11(S1):S201-5.